AZN vs. FSPSX

In the year-to-date period, AZN achieves a 7.67% return, which is significantly lower than FSPSX's 11.21% return. Over the past 10 years, AZN has outperformed FSPSX with an annualized return of 10.52%, while FSPSX has yielded a comparatively lower 5.36% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for AstraZeneca PLC (AZN) and Fidelity International Index Fund (FSPSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current AZN Sharpe Ratio is 0.01, which is lower than the FSPSX Sharpe Ratio of 0.70. The chart below compares the historical Sharpe Ratios of AZN and FSPSX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

AZN's dividend yield for the trailing twelve months is around 2.20%, less than FSPSX's 2.61% yield.

The maximum AZN drawdown since its inception was -48.94%, which is greater than FSPSX's maximum drawdown of -33.69%. Use the drawdown chart below to compare losses from any high point for AZN and FSPSX. For additional features, visit the drawdowns tool.

AstraZeneca PLC (AZN) and Fidelity International Index Fund (FSPSX) have volatilities of 11.25% and 10.91%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.